Life Science Network
The Life Science Network is the destination for life science professionals who wish to network, communicate, share ideas and connect with others. Our group is composed of executives, scientists, entrepreneurs, investors and media across biotechnology, pharmaceutical, medical technology, diagnostics and research communities.
Most importantly, the Life Science Network brings no industry agenda. You won't find us pushing promotion disguised as learning. We come together for easy communication, to make new connections, find new ways to collaborate, and help one another find the latest jobs or partnering opportunities. Join us!
July 25, 2014
Posted by Dr Paul Avery on Assignment
The ON Helix 2014 conference, hosted by One Nucleus, brought together a distinguished list of individuals to discuss the opportunities and challenges surrounding translational research here in the UK. The conference provided us with a plethora of novel data to sink our teeth into as well as a good amount of lively discussion to top it off. From labs to boardrooms, ON Helix had something for everyone. Here are some of our highlights.
July 25, 2014
Posted by Billy Hinchen on Assignment
There was no shortage of ‘oohs’ and ‘ahhs’ in Northampton at ELRIG’s recent Robotics and Automation 2014 Conference (1st July), hosted by Festo. From an impressive selection of companies in the exhibition room to fascinating talks on the evolution of high throughput screening, computer active learning and the future of computer user interfaces (UIs), people were kept on the edges of their seats; hidden beneath a few of which were even tokens for a fluidic-muscle driven F1 racing simulator race contest! Oooh! Read on for a few of our favourite highlights from the event.
June 25, 2014
Posted by Kelly Quigley on Assignment
Real estate activity is a telling indicator of industry growth for any sector, and biotech is no exception. In a report released at the 2014 BIO International Convention on Wednesday, real estate management and outsourcing firm JLL ranked the top U.S. markets for life science, as well as the top 10 global cities to watch.
While the report revealed few surprises, it did highlight one important trend: A shift from big pharma to mid-tier companies, small companies, and specialty players.